10X Genomics (TXG) PT Raised to $70 at Morgan Stanley
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
Tweet
Share
E-mailGet Alerts TXG Hot Sheet
Price: $76.42 +6.94%
Rating Summary:
8 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 17 | New: 13
Rating Summary:
8 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 17 | New: 13
Join SI Premium – FREE
Morgan Stanley analyst Kallum Titchmarsh raised the price target on 10X Genomics (NASDAQ: TXG) to $70.00 (from $40.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Torex Gold adds ex-KPMG mining leader to its board of directors
- salesforce.com (CRM) PT Raised to $250 at DA Davidson on Braze Deal
- Southern Co. (SO) PT Lowered to $98 at BMO Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
